Ahmad W, Ebert PR (2017) Metformin attenuates Aβ pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. Elegans model of Alzheimer’s disease. Mol Neurobiol 54:5427–5439
Article CAS PubMed Google Scholar
Ahmad R, Khan A, Rehman IU, Lee HJ, Khan I, Kim MO (2022) Lupeol treatment attenuates activation of glial cells and oxidative-stress-mediated neuropathology in mouse model of traumatic brain Injury. Int J Mol Sci 23(11):6086
Article CAS PubMed PubMed Central Google Scholar
Ahmed S, Mahmood Z, Javed A, Hashmi SN, Zerr I, Zafar S, Zahid S (2017) Effect of metformin on adult hippocampal neurogenesis: comparison with donepezil and links to cognition. J Mol Neurosci 62:88–98
Article CAS PubMed Google Scholar
Akhtar A, Dhaliwal J, Sah SP (2021) 7, 8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer’s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance. Psychopharmacology 238:1991–2009
Article CAS PubMed Google Scholar
Araujo WL, Nunes-Nesi AD, Nikoloski Z, Sweetlove LJ, Fernie AR (2012) Metabolic control and regulation of the tricarboxylic acid cycle in photosynthetic and heterotrophic plant tissues. Plant Cell Environ 35(1):1–21
Badshah H, Ali T, Rehman SU, Amin FU, Ullah F, Kim TH, Kim MO (2016) Protective effect of lupeol against lipopolysaccharide-induced neuroinflammation via the p38/c-Jun N-terminal kinase pathway in the adult mouse brain. J Neuroimmune Pharmacol 11:48–60
Banchroft JD, Stevens A, Turner DR (1996) Theory and practice of histological techniques, Fourth ed. Churchil Livingstone, New York, London, San Francisco, Tokyo
Ben nejma A, Besbes M, Guérineau V, Touboul D (2017) Isolation and structure elucidation of acetylcholinesterase lipophilic lupeol derivatives inhibitors from the latex of the Tunisian Periploca laevigata. Arab J Chem 10:S2767–S2772
Beutler E, Kelly BM (1963) The effect of sodium nitrite on red cell. GSH Experientia 19(2):96–97
Article CAS PubMed Google Scholar
Bhatia P, Singh N (2021) Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of Streptozotocin diabetes induced dementia. Physiol Behav 241:113592
Article CAS PubMed Google Scholar
Brandes MS, Gray NE (2020) NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro 12:1759091419899782. https://doi.org/10.1177/1759091419899782
Cheang WS, Tian XY, Wong WT, Lau CW, Lee SS, Chen ZY, Yao X, Wang N, Huang Y (2014) Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5′ adenosine monophosphate–activated protein kinase–peroxisome proliferator–activated receptor δ pathway. Arterioscler Thromb Vasc Biol 34(4):830–836
Article CAS PubMed Google Scholar
Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J 285(19):3576–3590
Article CAS PubMed PubMed Central Google Scholar
DiTacchio KA, Heinemann SF, Dziewczapolski G (2015) Metformin treatment alters memory function in a mouse model of Alzheimer’s disease. J Alzheimers Dis 44(1):43–48
Article CAS PubMed PubMed Central Google Scholar
Farr SA, Roesler E, Niehoff ML, Roby DA, McKee A, Morley JE (2019) Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. J Alzheimers Dis 68(4):1699–1710
Article CAS PubMed Google Scholar
Feng Y, Wang X (2012). Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev 2012:472932. https://doi.org/10.1155/2012/472932
Ganguly U, Kaur U, Chakrabarti SS, Sharma P, Agrawal BK, Saso L, Chakrabarti S (2021) Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer’s disease. Oxidative Med Cell Longev 2021:1–9
Grisham MB, Benoit JN, Granger DN (1990) Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186:729–742
Article CAS PubMed Google Scholar
Gurovic MS, Castro MJ, Richmond V, Faraoni MB, Maier MS, Murray AP (2010) Triterpenoids with acetylcholinesterase inhibition from Chuquiraga Erinacea D. Don. subsp. erinacea (Asteraceae). Planta Med 76(06):607–610
Article CAS PubMed Google Scholar
Gurupriya S, Cathrine L, Ramesh J (2018) In vitro antidiabetic and antioxidant activities of lupeol isolated from the methanolic extract of Andrographis echioides leaves. J Pharmacogn Phytochem 7(4):768–775
Hadjira S, Mansour A, Seghiri R, Menad A, Benayache F, Benayache S, Ameddah S (2021) Neuroinflammation and behavioral deficit in rotenone-induced neurotoxicity in rats and the possible effects of butanolic extract of Centaurea Africana. Recent Adv Inflamm Allergy Drug Discovery 15(1):35–43
https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed Jan 2022
Huang S, Mo C, Zeng T, Lai Y, Zhou C, Xie S, Chen L, Wang Y, Chen Y, Huang S, Gao L (2021) Lupeol ameliorates LPS/D-GalN induced acute hepatic damage by suppressing inflammation and oxidative stress through TGFβ1-Nrf2 signal pathway. Aging 13(5):6592
Article CAS PubMed PubMed Central Google Scholar
Johnson DA, Johnson JA (2015) Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88:253–267
Article CAS PubMed PubMed Central Google Scholar
Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U, Jeong GS, Choi DY (2017) Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson’s disease. Neuropharmacology 125:396–407
Article CAS PubMed Google Scholar
Katila N, Bhurtel S, Park PH, Choi DY (2021) Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway. Neurochem Int 148:105120
Article CAS PubMed Google Scholar
Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M (2022) Metformin in Alzheimer’s disease: an overview of potential mechanisms, preclinical and clinical findings. Biochem Pharmacol 5:114945
Klann IP, Martini F, Rosa SG, Nogueira CW (2020) Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer’s disease. Mol Biol Rep 47:2205–2215
Article CAS PubMed Google Scholar
Kumar A, Singh N (2017) Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer’s type. Biomed Pharmacother 88:698–707
Article CAS PubMed Google Scholar
Kumar A, Singh N (2018) Calcineurin inhibition and protein kinase A activation limits cognitive dysfunction and histopathological damage in a model of dementia of the Alzheimer’s type. Curr Neurovasc Res 15(3):234–245
Article CAS PubMed Google Scholar
Liu K, Zhang X, Xie L, Deng M, Chen H, Song J, Long J, Li X, Luo J (2021) Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy. Pharmacol Res 164:105373. https://doi.org/10.1016/j.phrs.2020.105373
Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Article CAS PubMed Google Scholar
Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G (2016) Metformin prevents dopaminergic neuron death in MPTP/P-Induced mouse model of Parkinson's disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol 19(9):pyw047. https://doi.org/10.1093/ijnp/pyw047
Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401–426
Article CAS PubMed PubMed Central Google Scholar
Madhu LN, Kodali M, Shetty AK (2022) Promise of metformin for preventing age-related cognitive dysfunction. Neural Regeneration Res 17(3):503
Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM (2017) Metformin–A future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in Alzheimer’s disease Guest Editor: Davide Brambilla. Pharm Res 34:2614–2627
Article CAS PubMed PubMed Central Google Scholar
Merelli A, Repetto M, Lazarowski A, Auzmendi J (2021) Hypoxia, oxidative stress, and inflammation: three faces of neurodegenerative diseases. J Alzheimers Dis 82(s1):S109–S126
Comments (0)